US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India’s pharmaceutical sector. This sector is vital for affordable medicines and economic stability, with the US market representing 30% of Indian exports.
The Headlines – Business News: Budget 2025, Business News Today, Latest Business News, Stock Markets, Financial News, India Business & World Business News – Read More